Saudi Arabia medicine data and pricing are newest addition to Pharma14.

Saudi Arabia's deep commitment to health care should bring it's pharmaceutical spending to the average developed market expenditure by 2020.
Saudi Arabia with a population of 33 million people will spend roughly $300 per person on pharmaceuticals by 2020.
Pharma14 is happy to announce the addition of Saudi Arabia to its global medicine database.
This is just the latest addition to our platform that now comprises close to 2,000,000 registered medicines across 41 countries.
As in all other countries, Saudi Arabia's monthly updated medicine knowledge base includes pricing, reimbursement information and much more.
Pharma14's robust and accurate medicine data, as well as its industry leading drug pricing and reimbursement information give its members the tools required to compete in today's market.
Key pricing drivers such as generics, parallel trade, biosimillars, niche markets and more provide unique industry insight.
 
Sample Saudi Arabia data: Lenalidomide competitive landscape.  5 mg, 10 mg, 15 mg, 25 mg capsules. Ex-factory, wholesale and retail pricing. Revlimid and Lenalidomide spc.
 
Saudi Arabia Lenalidomide competitive landscape.  5 mg, 10 mg, 15 mg, 25 mg capsules. Ex-factory, wholesale and retail pricing. Revlimid and Lenalidomide spc.


CONTACT US

60 Medinat Hayehudim St.

Entrance C. Third floor.

Herzeliya, 46766

Israel

+1-212-220-3600

info@pharma14.com

ASK YOUR QUESTION



Drug Price